{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:24Z","timestamp":1790888724338,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CRP-23-1014041"],"award-info":[{"award-number":["CRP-23-1014041"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA167552"],"award-info":[{"award-number":["U01 CA167552"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["NCI UM1 CA186107"],"award-info":[{"award-number":["NCI UM1 CA186107"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["NCI U01 CA176726"],"award-info":[{"award-number":["NCI U01 CA176726"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R00DK119412"],"award-info":[{"award-number":["R00DK119412"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1 AG083764"],"award-info":[{"award-number":["RF1 AG083764"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG077489"],"award-info":[{"award-number":["R01AG077489"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01NR01999"],"award-info":[{"award-number":["R01NR01999"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00125-025-06441-3","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:12:03Z","timestamp":1746184323000},"page":"1696-1708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts"],"prefix":"10.1007","volume":"68","author":[{"given":"Yiwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir J.","family":"Stampfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"issue":"9","key":"6441_CR1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1345\/aph.1L181","volume":"42","author":"D Mann","year":"2008","unstructured":"Mann D, Reynolds K, Smith D, Muntner P (2008) Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother 42(9):1208\u20131215. https:\/\/doi.org\/10.1345\/aph.1L181","journal-title":"Ann Pharmacother"},{"issue":"25 Pt B","key":"6441_CR2","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","volume":"63","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63(25 Pt B):2889\u20132934. https:\/\/doi.org\/10.1016\/j.jacc.2013.11.002","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"6441_CR3","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL et al (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(25):e1082\u2013e1143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"issue":"15","key":"6441_CR4","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","volume":"370","author":"MJ Pencina","year":"2014","unstructured":"Pencina MJ, Navar-Boggan AM, D\u2019Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED (2014) Application of new cholesterol guidelines to a population-based sample. N Engl J Med 370(15):1422\u20131431. https:\/\/doi.org\/10.1056\/NEJMoa1315665","journal-title":"N Engl J Med"},{"issue":"6","key":"6441_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jsps.2023.04.002","volume":"31","author":"A Matyori","year":"2023","unstructured":"Matyori A, Brown CP, Ali A, Sherbeny F (2023) Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines. Saudi Pharm J 31(6):795\u2013800. https:\/\/doi.org\/10.1016\/j.jsps.2023.04.002","journal-title":"Saudi Pharm J"},{"issue":"21","key":"6441_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195\u20132207. https:\/\/doi.org\/10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"issue":"14","key":"6441_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","volume":"57","author":"DD Waters","year":"2011","unstructured":"Waters DD, Ho JE, DeMicco DA et al (2011) Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol 57(14):1535\u20131545. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.047","journal-title":"J Am Coll Cardiol"},{"issue":"9841","key":"6441_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","volume":"380","author":"PM Ridker","year":"2012","unstructured":"Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ (2012) Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380(9841):565\u2013571. https:\/\/doi.org\/10.1016\/S0140-6736(12)61190-8","journal-title":"Lancet"},{"issue":"9965","key":"6441_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB et al (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385(9965):351\u2013361. https:\/\/doi.org\/10.1016\/S0140-6736(14)61183-1","journal-title":"Lancet"},{"issue":"22","key":"6441_CR10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD et al (2016) Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med 375(22):2144\u20132153. https:\/\/doi.org\/10.1056\/NEJMoa1604304","journal-title":"N Engl J Med"},{"issue":"2","key":"6441_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","volume":"172","author":"AL Culver","year":"2012","unstructured":"Culver AL, Ockene IS, Balasubramanian R et al (2012) Statin use and risk of diabetes mellitus in postmenopausal women in the Women\u2019s Health Initiative. Arch Intern Med 172(2):144\u2013152. https:\/\/doi.org\/10.1001\/archinternmed.2011.625","journal-title":"Arch Intern Med"},{"issue":"5","key":"6441_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/bcp.13898","volume":"85","author":"F Ahmadizar","year":"2019","unstructured":"Ahmadizar F, Ochoa-Rosales C, Glisic M, Franco OH, Muka T, Stricker BH (2019) Associations of statin use with glycaemic traits and incident type 2 diabetes. Br J Clin Pharmacol 85(5):993\u20131002. https:\/\/doi.org\/10.1111\/bcp.13898","journal-title":"Br J Clin Pharmacol"},{"issue":"46","key":"6441_CR13","doi-asserted-by":"publisher","first-page":"e5429","DOI":"10.1097\/MD.0000000000005429","volume":"95","author":"D Yoon","year":"2016","unstructured":"Yoon D, Sheen SS, Lee S, Choi YJ, Park RW, Lim HS (2016) Statins and risk for new-onset diabetes mellitus: a real-world cohort study using a clinical research database. Medicine (Baltimore) 95(46):e5429. https:\/\/doi.org\/10.1097\/MD.0000000000005429","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6441_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","volume":"58","author":"H Cederberg","year":"2015","unstructured":"Cederberg H, Stancakova A, Yaluri N, Modi S, Kuusisto J, Laakso M (2015) Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia 58(5):1109\u20131117. https:\/\/doi.org\/10.1007\/s00125-015-3528-5","journal-title":"Diabetologia"},{"issue":"5","key":"6441_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.numecd.2017.03.001","volume":"27","author":"M Casula","year":"2017","unstructured":"Casula M, Mozzanica F, Scotti L et al (2017) Statin use and risk of new-onset diabetes: a meta-analysis of observational studies. Nutr Metab Cardiovasc Dis 27(5):396\u2013406. https:\/\/doi.org\/10.1016\/j.numecd.2017.03.001","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"6441_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/dom.12254","volume":"16","author":"DS Bell","year":"2014","unstructured":"Bell DS, DiNicolantonio JJ, O\u2019Keefe JH (2014) Is statin-induced diabetes clinically relevant? A comprehensive review of the literature. Diabetes Obes Metab 16(8):689\u2013694. https:\/\/doi.org\/10.1111\/dom.12254","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"6441_CR17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","volume":"106","author":"Y Bao","year":"2016","unstructured":"Bao Y, Bertoia ML, Lenart EB, Stampfer MJ, Willett WC, Speizer FE, Chavarro JE (2016) Origin, methods, and evolution of the three Nurses\u2019 Health Studies. Am J Public Health 106(9):1573\u20131581. https:\/\/doi.org\/10.2105\/AJPH.2016.303338","journal-title":"Am J Public Health"},{"issue":"5","key":"6441_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/oxfordjournals.aje.a114319","volume":"123","author":"GA Colditz","year":"1986","unstructured":"Colditz GA, Martin P, Stampfer MJ et al (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894\u2013900. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a114319","journal-title":"Am J Epidemiol"},{"issue":"7404","key":"6441_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326(7404):1423. https:\/\/doi.org\/10.1136\/bmj.326.7404.1423","journal-title":"BMJ"},{"issue":"6","key":"6441_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/00001648-199011000-00009","volume":"1","author":"EB Rimm","year":"1990","unstructured":"Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466\u2013473. https:\/\/doi.org\/10.1097\/00001648-199011000-00009","journal-title":"Epidemiology"},{"issue":"1","key":"6441_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/oxfordjournals.aje.a114086","volume":"122","author":"WC Willett","year":"1985","unstructured":"Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122(1):51\u201365. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a114086","journal-title":"Am J Epidemiol"},{"issue":"7","key":"6441_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/aje\/kww104","volume":"185","author":"C Yuan","year":"2017","unstructured":"Yuan C, Spiegelman D, Rimm EB et al (2017) Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol 185(7):570\u2013584. https:\/\/doi.org\/10.1093\/aje\/kww104","journal-title":"Am J Epidemiol"},{"issue":"6","key":"6441_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/aje\/kwaa280","volume":"190","author":"L Al-Shaar","year":"2021","unstructured":"Al-Shaar L, Yuan C, Rosner B et al (2021) Reproducibility and validity of a semiquantitative food frequency questionnaire in men assessed by multiple methods. Am J Epidemiol 190(6):1122\u20131132. https:\/\/doi.org\/10.1093\/aje\/kwaa280","journal-title":"Am J Epidemiol"},{"issue":"6","key":"6441_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3945\/jn.111.157222","volume":"142","author":"SE Chiuve","year":"2012","unstructured":"Chiuve SE, Fung TT, Rimm EB et al (2012) Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 142(6):1009\u20131018. https:\/\/doi.org\/10.3945\/jn.111.157222","journal-title":"J Nutr"},{"issue":"7","key":"6441_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7):1183\u20131197. https:\/\/doi.org\/10.2337\/diacare.20.7.1183","journal-title":"Diabetes Care"},{"issue":"8770","key":"6441_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/0140-6736(91)90664-b","volume":"338","author":"JE Manson","year":"1991","unstructured":"Manson JE, Rimm EB, Stampfer MJ et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338(8770):774\u2013778. https:\/\/doi.org\/10.1016\/0140-6736(91)90664-b","journal-title":"Lancet"},{"issue":"12","key":"6441_CR27","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1001\/archinte.161.12.1542","volume":"161","author":"FB Hu","year":"2001","unstructured":"Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161(12):1542\u20131548. https:\/\/doi.org\/10.1001\/archinte.161.12.1542","journal-title":"Arch Intern Med"},{"issue":"13","key":"6441_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/archinte.161.13.1581","volume":"161","author":"AE Field","year":"2001","unstructured":"Field AE, Coakley EH, Must A et al (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161(13):1581\u20131586. https:\/\/doi.org\/10.1001\/archinte.161.13.1581","journal-title":"Arch Intern Med"},{"issue":"11","key":"6441_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/oxfordjournals.aje.a117191","volume":"140","author":"JW Rich-Edwards","year":"1994","unstructured":"Rich-Edwards JW, Corsano KA, Stampfer MJ (1994) Test of the national death index and equifax nationwide death search. Am J Epidemiol 140(11):1016\u20131019. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a117191","journal-title":"Am J Epidemiol"},{"issue":"1","key":"6441_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ije\/dyq165","volume":"40","author":"S Mendis","year":"2011","unstructured":"Mendis S, Thygesen K, Kuulasmaa K et al (2011) World Health Organization definition of myocardial infarction: 2008\u201309 revision. Int J Epidemiol 40(1):139\u2013146. https:\/\/doi.org\/10.1093\/ije\/dyq165","journal-title":"Int J Epidemiol"},{"issue":"2 Pt 2 Suppl 1","key":"6441_CR31","first-page":"I13","volume":"12","author":"AE Walker","year":"1981","unstructured":"Walker AE, Robins M, Weinfeld FD (1981) The National Survey of Stroke Clinical findings. Stroke 12(2 Pt 2 Suppl 1):I13\u2013I44","journal-title":"Stroke"},{"key":"6441_CR32","doi-asserted-by":"publisher","first-page":"k4641","DOI":"10.1136\/bmj.k4641","volume":"363","author":"Z Shan","year":"2018","unstructured":"Shan Z, Li Y, Zong G et al (2018) Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses. BMJ 363:k4641. https:\/\/doi.org\/10.1136\/bmj.k4641","journal-title":"BMJ"},{"key":"6441_CR33","doi-asserted-by":"publisher","first-page":"n1537","DOI":"10.1136\/bmj.n1537","volume":"374","author":"T Cai","year":"2021","unstructured":"Cai T, Abel L, Langford O et al (2021) Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses. BMJ 374:n1537. https:\/\/doi.org\/10.1136\/bmj.n1537","journal-title":"BMJ"},{"issue":"9346","key":"6441_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/s0140-6736(02)11600-x","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB et al (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360(9346):1623\u20131630. https:\/\/doi.org\/10.1016\/s0140-6736(02)11600-x","journal-title":"Lancet"},{"issue":"8","key":"6441_CR35","doi-asserted-by":"publisher","first-page":"e011320","DOI":"10.1161\/JAHA.118.011320","volume":"8","author":"MJ Ko","year":"2019","unstructured":"Ko MJ, Jo AJ, Kim YJ et al (2019) Time- and dose-dependent association of statin use with risk of clinically relevant new-onset diabetes mellitus in primary prevention: a nationwide observational cohort study. J Am Heart Assoc 8(8):e011320. https:\/\/doi.org\/10.1161\/JAHA.118.011320","journal-title":"J Am Heart Assoc"},{"key":"6441_CR36","doi-asserted-by":"publisher","first-page":"f2610","DOI":"10.1136\/bmj.f2610","volume":"346","author":"AA Carter","year":"2013","unstructured":"Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM (2013) Risk of incident diabetes among patients treated with statins: population based study. BMJ 346:f2610. https:\/\/doi.org\/10.1136\/bmj.f2610","journal-title":"BMJ"},{"key":"6441_CR37","doi-asserted-by":"publisher","first-page":"g3244","DOI":"10.1136\/bmj.g3244","volume":"348","author":"CR Dormuth","year":"2014","unstructured":"Dormuth CR, Filion KB, Paterson JM et al (2014) Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases. BMJ 348:g3244. https:\/\/doi.org\/10.1136\/bmj.g3244","journal-title":"BMJ"},{"issue":"10","key":"6441_CR38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/pds.4020","volume":"25","author":"D Thakker","year":"2016","unstructured":"Thakker D, Nair S, Pagada A, Jamdade V, Malik A (2016) Statin use and the risk of developing diabetes: a network meta-analysis. Pharmacoepidemiol Drug Saf 25(10):1131\u20131149. https:\/\/doi.org\/10.1002\/pds.4020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"6441_CR39","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1161\/ATVBAHA.121.316159","volume":"41","author":"F Abbasi","year":"2021","unstructured":"Abbasi F, Lamendola C, Harris CS et al (2021) Statins are associated with increased insulin resistance and secretion. Arterioscler Thromb Vasc Biol 41(11):2786\u20132797. https:\/\/doi.org\/10.1161\/ATVBAHA.121.316159","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"6441_CR40","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","volume":"55","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK (2010) Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol 55(12):1209\u20131216. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.053","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"6441_CR41","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.2337\/db13-1398","volume":"63","author":"BD Henriksbo","year":"2014","unstructured":"Henriksbo BD, Lau TC, Cavallari JF et al (2014) Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance. Diabetes 63(11):3742\u20133747. https:\/\/doi.org\/10.2337\/db13-1398","journal-title":"Diabetes"},{"issue":"8","key":"6441_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","volume":"111","author":"EP Navarese","year":"2013","unstructured":"Navarese EP, Buffon A, Andreotti F et al (2013) Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 111(8):1123\u20131130. https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.037","journal-title":"Am J Cardiol"},{"issue":"24","key":"6441_CR43","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","volume":"305","author":"D Preiss","year":"2011","unstructured":"Preiss D, Seshasai SR, Welsh P et al (2011) Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305(24):2556\u20132564. https:\/\/doi.org\/10.1001\/jama.2011.860","journal-title":"JAMA"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06441-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:01:36Z","timestamp":1777680096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6441"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06441-3","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We thank the Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, as home of the Health Professionals Follow-up Study and Nurses\u2019 Health Studies. Some of the data were presented as an abstract at the American Heart Association\u2019s Epidemiology and Prevention\/Lifestyle and Cardiometabolic Health Scientific Sessions meeting in 2015.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"Because of participant confidentiality and privacy concerns, data cannot be shared publicly, and requests to access NHS\/NHSII\/HPFS data must be submitted in writing. The procedures to follow to obtain and access data from these are described at\n                      \n                      (contact nhsaccess@channing.harvard.edu) and\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The Health Professionals Follow-up Study is supported by grant number U01 CA167552 from the National Cancer Institute (NCI). The Nurses\u2019 Health Study is supported by grant number UM1 CA186107 from the NCI. The Nurses\u2019 Health Study II is supported by grant numbers U01 CA176726 from the NCI and grant number U01 HL145386 from the National Heart, Lung and Blood Institute. ELG is funded as an American Cancer Society Clinical Research Professor (grant CRP-23-1014041). DDW is supported by grant numbers R00DK119412, RF1 AG083764, R01AG077489 and R01NR019992 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the design or conduct of the study; collection, management, analysis or interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"YZ and DDW wrote the first draft of the manuscript and performed the analyses. YZ, DDW, FBH and ELG designed the research. YLi and YLiu provided statistical expertise. All authors contributed to the interpretation for the results and critical revision of the manuscript for important intellectual content and approved the final version of the manuscript. YZ and DDW are the guarantors of this work, and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}